NHS Framework Agreement for the Supply of Direct Oral Anticoagulant (DOAC) Medicines for the NHS in England

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£3B
Sector
HEALTH
Published
25 Nov 2021
Delivery
not specified
Deadline
n/a

Concepts

Location

Yorkshire and the Humber: England

Geochart for 1 buyers and 3 suppliers

1 buyer

3 suppliers

Description

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs).Period of Framework: 01/01/2022 - 31/04/2024 with an option to extend (at the Authority’s discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 39 months)

Award Detail

1 Bristol Myers Squibb (Uxbridge)
  • Reference: 029382-2021-1
  • Value: £3,185,000,000
2 Bayer (Reading)
  • Reference: 029382-2021-2
  • Value: £3,185,000,000
3 Daiichi Sankyo (Uxbridge)
  • Reference: 029382-2021-3
  • Value: £3,185,000,000

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products
  • 33690000 - Various medicinal products

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains